These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 22571612)
1. NMR in drug discovery on membrane proteins. Wirmer-Bartoschek J; Bartoschek S Future Med Chem; 2012 May; 4(7):869-75. PubMed ID: 22571612 [TBL] [Abstract][Full Text] [Related]
2. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy. Maurer T Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602 [TBL] [Abstract][Full Text] [Related]
3. Solution NMR study of integral membrane proteins. Kang C; Li Q Curr Opin Chem Biol; 2011 Aug; 15(4):560-9. PubMed ID: 21684799 [TBL] [Abstract][Full Text] [Related]
8. [NMR in the fragment-based drug discovery]. Hanzawa H; Takizawa T Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1617-21. PubMed ID: 21089597 [No Abstract] [Full Text] [Related]
9. NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Meyer B; Peters T Angew Chem Int Ed Engl; 2003 Feb; 42(8):864-90. PubMed ID: 12596167 [TBL] [Abstract][Full Text] [Related]
10. Solid-state magic-angle spinning NMR of membrane proteins and protein-ligand interactions. Franks WT; Linden AH; Kunert B; van Rossum BJ; Oschkinat H Eur J Cell Biol; 2012 Apr; 91(4):340-8. PubMed ID: 22019511 [TBL] [Abstract][Full Text] [Related]
11. Structure and orientation of ligands bound to membrane proteins are reflected by residual dipolar couplings in solution NMR measurements. Koenig BW Chembiochem; 2002 Oct; 3(10):975-80. PubMed ID: 12362362 [No Abstract] [Full Text] [Related]
12. An accurate pharmacophore mapping method by NMR spectroscopy. Mizukoshi Y; Abe A; Takizawa T; Hanzawa H; Fukunishi Y; Shimada I; Takahashi H Angew Chem Int Ed Engl; 2012 Feb; 51(6):1362-5. PubMed ID: 22213544 [No Abstract] [Full Text] [Related]
13. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification. Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886 [TBL] [Abstract][Full Text] [Related]
14. NMR in structure-based drug design. Carneiro MG; Ab E; Theisgen S; Siegal G Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095 [TBL] [Abstract][Full Text] [Related]
16. Techniques and applications of NMR to membrane proteins. Nielsen N; Malmendal A; Vosegaard T Mol Membr Biol; 2004; 21(3):129-41. PubMed ID: 15204621 [TBL] [Abstract][Full Text] [Related]
17. Structure-based drug discovery and protein targets in the CNS. Hubbard RE Neuropharmacology; 2011 Jan; 60(1):7-23. PubMed ID: 20673774 [TBL] [Abstract][Full Text] [Related]
18. Design and NMR-based screening of LEF, a library of chemical fragments with different local environment of fluorine. Vulpetti A; Hommel U; Landrum G; Lewis R; Dalvit C J Am Chem Soc; 2009 Sep; 131(36):12949-59. PubMed ID: 19702332 [TBL] [Abstract][Full Text] [Related]
19. Nuclear magnetic resonance-based screening methods for drug discovery. Sillerud LO; Larson RS Methods Mol Biol; 2006; 316():227-89. PubMed ID: 16671407 [TBL] [Abstract][Full Text] [Related]
20. NMR in the acceleration of drug discovery. Sem DS; Pellecchia M Curr Opin Drug Discov Devel; 2001 Jul; 4(4):479-92. PubMed ID: 11727313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]